Sanofi Canada focuses in on cancer research

Sanofi Canada President and CEO visits BC's Genetic Pathology Evaluation Centre 

MONTREAL, Feb. 1, 2012 /CNW Telbec/ - Hugh O'Neill, Sanofi Canada's President and CEO (standing) and Dr. Torsten Nielsen,Co-Director of the Genetic Pathology Evaluation Centre in Vancouver, BC, discuss the latest advances in microarray technology. Sanofi Canada has a ten-year research collaboration with the Centre, supporting their mission to improve cancer diagnosis, assessment and treatment.

Image with caption: "Hugh O'Neill, Sanofi Canada's President and CEO (standing) and Dr. Torsten Nielsen, Co-Director of the Genetic Pathology Evaluation Centre in Vancouver, BC, discuss the latest advances in microarray technology. Sanofi Canada has a ten-year research collaboration with the Centre, supporting their mission to improve cancer diagnosis, assessment and treatment. (CNW Group/Sanofi Canada)". Image available at: http://photos.newswire.ca/images/download/20120201_C8511_PHOTO_EN_9497.jpg